Eli Lilly to buy Merida Biosciences in deal worth up to $2.88 billion
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
Overview
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
Source
Originally published at www.cnbc.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.